menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Renaissance Lakewood Backs ARS Pharma’s Nasal Spray For Allergies

    PRESS RELEASE

    Renaissance Lakewood Completes Campus Enhancement Project

    CONTRACT PHARMA

    Renaissance Opens New HQ Global Cdmo Makes Addi. Invet In Ocean County,Nj Campus

    PRESS RELEASE

    The role of CDMOs in overcoming nasal drug delivery R&D & Mfg challenges

    PRESS RELEASE

    Q&A with European Pharmaceutical Manufacturer Magazine

    PRESS RELEASE

    Essential Pharma Acquires Renaissance for Neuroblastoma Therapy.

    GLOBENEWSWIRE

    Essential completes acquisition of Renaissance its clinical stage immunotherapy

    PHARMABIZ

    Renaissance Lakewood Excels In Nasal Product R&D And Clinical Manufacturing

    PRESS RELEASE

    Renaissance Pharma launches today & announces the in-licensing of Hu14.18K322A

    GLOBENEWSWIRE

    Renaissance Lakewood Invests in Additional High-Speed Nasal Spray Assembly Capability

    CONTRACT PHARMA

    The Renaissance of Small Molecule Drug Discovery

    CONTRACTPHARMA

    Renaissance SSA`s Generic Naloxone Hydrochloride Receives Approval in US

    FDA

    Renaissance`s Generic Dicyclomine Hydrochloride Receives Approval in US

    FDA

    Renaissance`s Generic Neostigmine Methylsulfate Receives Approval in US

    FDA

    Renaissance’s Generic Sodium Nitroprusside Receives Approval In US

    FDA

    Renaissance’s Generic Succinylcholine Chloride Receives Approval In US

    FDA

    Enforcement Report - Week of April 25, 2018

    FDA

    Enforcement Report - Week of December 27, 2017

    FDA

    Renaissance’s Generic Pentobarbital Sodium Receives Approval In US

    FDA

    Renaissance’s Generic Oxacillin Sodium Receives Approval In US

    FDA

    Renaissance’s Generic Mesalamine Receives Approval In US

    FDA

    Renaissance`s Generic Methocarbamol Receives Approval In US

    FDA

    Hillary Clinton`s medical condition May be taking dangerous drug Levaquin

    PR NEWSWIRE

    Mylan Completes Acquisition of Renaissance`s Leading Topicals

    PR NEWSWIRE

    Lakewood-Amedex Inc. Appoints Chief Medical Officer And Chief Scientific Officer To Enhance Drug Development And Clinical Trials Programs

    PR NEWS WIRE

    German Drugmakers Appeal Drug Suspensions Linked to Indian Data

    REUTERS

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.